Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Andrew J. MacGinnitie MD, PhD

Chief, Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Allergy

Publications (33)

  • Rethinking Immunological Risk: A Retrospective Cohort Study of Severe SARS-Cov-2 Infections in Individuals With Congenital Immunodeficiencies. (Nguyen AA, Habiballah SB, LaBere B, Day-Lewis M, Elkins M, Al-Musa A, Chu A, Jones J, Fried AJ, McDonald D, Hoytema van Konijnenburg DP, Rockowitz S, Sliz P, Oettgen HC, Schneider LC, MacGinnitie A, Bartnikas LM, Platt CD, Ohsumi TK, Chou J) J Allergy Clin Immunol Pract 2023 Nov;11(11):3391-3399.e3 PMID: 37544429 PMCID: PMC10839118 SCOPUS ID: 2-s2.0-85170438340 08/07/2023       1 Citation
  • High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy. (Chen G, Shrock EL, Li MZ, Spergel JM, Nadeau KC, Pongracic JA, Umetsu DT, Rachid R, MacGinnitie AJ, Phipatanakul W, Schneider L, Oettgen HC, Elledge SJ) Cell Rep Med 2021 Oct 19;2(10):100410 PMID: 34755130 PMCID: PMC8563412 SCOPUS ID: 2-s2.0-85120717433 11/11/2021       27 Citations
  • Development and Validation of the Asthma Exacerbation Risk Score Using Claims Data. (Hatoun J, Correa ET, MacGinnitie AJ, Gaffin JM, Vernacchio L) Acad Pediatr 2022;22(1):47-54 PMID: 34256177 SCOPUS ID: 2-s2.0-85112107825 07/14/2021       5 Citations
  • Predicting outcomes of baked egg and baked milk oral food challenges by using a ratio of food-specific IgE to total IgE. (Esty B, Maciag MC, Bartnikas LM, Petty CR, MacGinnitie AJ, Sheehan WJ, Phipatanakul W) J Allergy Clin Immunol Pract 2021 Apr;9(4):1750-1752.e1 PMID: 33217611 PMCID: PMC8043965 SCOPUS ID: 2-s2.0-85103637770 11/21/2020       4 Citations
  • Utility of measuring tryptase levels in children and young adults. (Ahmed F, Fried AJ, Spielman S, Secor W, MacGinnitie AJ) Ann Allergy Asthma Immunol 2019 Oct;123(4):398-399 PMID: 31400462 SCOPUS ID: 2-s2.0-85071399650 08/11/2019       2 Citations
  • Immunoglobulin E blockade during food allergen ingestion enhances the induction of inhibitory immunoglobulin G antibodies. (Stranks AJ, Minnicozzi SC, Miller SJ, Burton OT, Logsdon SL, Spergel JM, Nadeau KC, Pongracic JA, Umetsu DT, Rachid R, MacGinnitie AJ, Schneider LC, Oettgen HC) Ann Allergy Asthma Immunol 2019 Feb;122(2):213-215 PMID: 30404033 PMCID: PMC6360101 SCOPUS ID: 2-s2.0-85057557002 11/08/2018       14 Citations
  • The Role of Food Challenges in Clinical Practice. (MacGinnitie AJ, Young MC) J Allergy Clin Immunol Pract 2018;6(2):353-360 PMID: 29524990 SCOPUS ID: 2-s2.0-85043570654 03/12/2018       9 Citations
  • Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. (Bird JA, Spergel JM, Jones SM, Rachid R, Assa'ad AH, Wang J, Leonard SA, Laubach SS, Kim EH, Vickery BP, Davis BP, Heimall J, Cianferoni A, MacGinnitie AJ, Crestani E, Burks AW, ARC001 Study Group) J Allergy Clin Immunol Pract 2018;6(2):476-485.e3 PMID: 29092786 SCOPUS ID: 2-s2.0-85032746719 11/03/2017       145 Citations
  • Multicenter prevalence of anaphylaxis in clinic-based oral food challenges. (Akuete K, Guffey D, Israelsen RB, Broyles JM, Higgins LJ, Green TD, Naimi DR, MacGinnitie AJ, Vitalpur G, Minard CG, Davis CM) Ann Allergy Asthma Immunol 2017 Oct;119(4):339-348.e1 PMID: 28890356 SCOPUS ID: 2-s2.0-85030620034 09/12/2017       52 Citations
  • Omalizumab facilitates rapid oral desensitization for peanut allergy. (MacGinnitie AJ, Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, Heimall J, Makhija M, Robison R, Chinthrajah RS, Lee J, Lebovidge J, Dominguez T, Rooney C, Lewis MO, Koss J, Burke-Roberts E, Chin K, Logvinenko T, Pongracic JA, Umetsu DT, Spergel J, Nadeau KC, Schneider LC) J Allergy Clin Immunol 2017 Mar;139(3):873-881.e8 PMID: 27609658 PMCID: PMC5369605 SCOPUS ID: 2-s2.0-84991239186 10/19/2016       226 Citations
  • Implementation of a Standardized Clinical Assessment and Management Plan (SCAMP) for Food Challenges. (Simberloff T, Parambi R, Bartnikas LM, Broyles AD, Hamel V, Timmons KG, Miller DM, Graham DA, Schneider LC, MacGinnitie AJ) J Allergy Clin Immunol Pract 2017;5(2):335-344.e3 PMID: 27373725 SCOPUS ID: 2-s2.0-85003587444 07/05/2016       20 Citations
  • Plasma-derived C1-INH for managing hereditary angioedema in pediatric patients: A systematic review. (Craig TJ, Schneider LC, MacGinnitie AJ) Pediatr Allergy Immunol 2015 Sep;26(6):537-44 PMID: 26111105 SCOPUS ID: 2-s2.0-84941216130 06/26/2015       14 Citations
  • Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks. (Craig TJ, Li HH, Riedl M, Bernstein JA, Lumry WR, MacGinnitie AJ, Stolz LE, Biedenkapp J, Chyung Y) J Allergy Clin Immunol Pract 2015;3(2):206-212.e4 PMID: 25609335 SCOPUS ID: 2-s2.0-84924204714 01/23/2015       38 Citations
  • Pediatric hereditary angioedema. (MacGinnitie AJ) Pediatr Allergy Immunol 2014 Aug;25(5):420-7 PMID: 24313851 PMCID: PMC4282351 SCOPUS ID: 2-s2.0-84907598749 12/10/2013       38 Citations
  • Use of ecallantide in pediatric hereditary angioedema. (MacGinnitie AJ, Davis-Lorton M, Stolz LE, Tachdjian R) Pediatrics 2013 Aug;132(2):e490-7 PMID: 23878046 SCOPUS ID: 2-s2.0-84882256379 07/24/2013       30 Citations
  • Analysis of hereditary angioedema attacks requiring a second dose of ecallantide. (Li HH, Campion M, Craig TJ, Soteres DF, Riedl M, Lumry WR, MacGinnitie AJ, Shea EP, Bernstein JA) Ann Allergy Asthma Immunol 2013 Mar;110(3):168-72 PMID: 23548526 SCOPUS ID: 2-s2.0-84875230696 04/04/2013       15 Citations
  • Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks. (Sheffer AL, MacGinnitie AJ, Campion M, Stolz LE, Pullman WE) Ann Allergy Asthma Immunol 2013 Mar;110(3):184-188.e2 PMID: 23548529 SCOPUS ID: 2-s2.0-84875214648 04/04/2013       25 Citations
  • Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study. (Lumry WR, Bernstein JA, Li HH, MacGinnitie AJ, Riedl M, Soteres DF, Craig TJ, Campion M, Iarrobino R, Stolz LE, Pullman WE) Allergy Asthma Proc 2013;34(2):155-61 PMID: 23484891 SCOPUS ID: 2-s2.0-84876003802 03/15/2013       27 Citations
  • Long-acting beta-agonists and the risk of intensive care unit admission in children. (Jacobs TS, Jones BL, MacGinnitie AJ) J Asthma 2012 Jun;49(5):450-5 PMID: 22540879 PMCID: PMC3676306 SCOPUS ID: 2-s2.0-84862850804 05/01/2012       6 Citations
  • Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics. (MacGinnitie AJ, Campion M, Stolz LE, Pullman WE) Allergy Asthma Proc 2012;33(2):178-85 PMID: 22525395 SCOPUS ID: 2-s2.0-84860234867 04/25/2012       14 Citations
  • Indoor allergen sensitization and the risk of asthma and eczema in children in Pittsburgh. (McHugh BM, MacGinnitie AJ) Allergy Asthma Proc 2011;32(5):372-6 PMID: 22195690 SCOPUS ID: 2-s2.0-80053413655 12/27/2011       19 Citations
  • Infant with unusual food reactions. (Ruffner MA, Finegold DN, MacGinnitie AJ) Acta Paediatr 2011 Oct;100(10):1289, 1394-5 PMID: 21916981 SCOPUS ID: 2-s2.0-80052859477 09/16/2011       1 Citation
  • 11q terminal deletion disorder and common variable immunodeficiency. (Puglisi G, Netravali MA, MacGinnitie AJ, Bonagura VR) Ann Allergy Asthma Immunol 2009 Sep;103(3):267-8 PMID: 19788026 SCOPUS ID: 2-s2.0-70349467526 10/01/2009       9 Citations
  • Chronic granulomatous disease in an adolescent with recurrent impetigo and cholecystectomy. (Scholnicoff ET, MacGinnitie AJ, Lin PL, Darville T) Pediatr Infect Dis J 2009 Mar;28(3):255-7 PMID: 19165129 SCOPUS ID: 2-s2.0-63449097930 01/24/2009       1 Citation
  • X-linked lymphoproliferative disease in an EBV-negative patient presenting with pancytopenia. (Kapadia SB, Macginnitie AJ, Shaw PH) Pediatr Blood Cancer 2008 Jun;50(6):1296-7 PMID: 18293382 SCOPUS ID: 2-s2.0-42349104650 02/23/2008       1 Citation
  • Management of an anaphylactoid reaction to methotrexate with a stepwise graded challenge. (MacGinnitie AJ, Walensky LD, Turvey SE, Orange JS, Bonilla FA, Silverman LB, Oettgen H) Pediatr Allergy Immunol 2003 Oct;14(5):409-11 PMID: 14641613 SCOPUS ID: 2-s2.0-0242416147 12/04/2003       12 Citations
  • X-linked lymphoproliferative disease: genetic lesions and clinical consequences. (MacGinnitie AJ, Geha R) Curr Allergy Asthma Rep 2002 Sep;2(5):361-7 PMID: 12165201 SCOPUS ID: 2-s2.0-0036718154 08/08/2002       10 Citations
  • Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. (Madsen P, Anant S, Rasmussen HH, Gromov P, Vorum H, Dumanski JP, Tommerup N, Collins JE, Wright CL, Dunham I, MacGinnitie AJ, Davidson NO, Celis JE) J Invest Dermatol 1999 Aug;113(2):162-9 PMID: 10469298 SCOPUS ID: 2-s2.0-0033511807 09/01/1999       50 Citations
  • A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity. (Anant S, Martin SA, Yu H, MacGinnitie AJ, Devaney E, Davidson NO) Mol Biochem Parasitol 1997 Sep;88(1-2):105-14 PMID: 9274872 SCOPUS ID: 2-s2.0-0030788338 09/01/1997       12 Citations
  • Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. (MacGinnitie AJ, Anant S, Davidson NO) J Biol Chem 1995 Jun 16;270(24):14768-75 PMID: 7782343 SCOPUS ID: 2-s2.0-0028997652 06/16/1995       114 Citations
  • apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. (Anant S, MacGinnitie AJ, Davidson NO) J Biol Chem 1995 Jun 16;270(24):14762-7 PMID: 7782342 SCOPUS ID: 2-s2.0-0029004350 06/16/1995       106 Citations
  • Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination. (Davidson NO, Anant S, MacGinnitie AJ) Curr Opin Lipidol 1995 Apr;6(2):70-4 PMID: 7773570 SCOPUS ID: 2-s2.0-0028905895 04/01/1995       34 Citations
  • The binding of apobec-1 to mammalian apo B RNA is stabilized by the presence of complementation factors which are required for post-transcriptional editing. (Anant S, MacGinnitie AJ, Davidson NO) Nucleic Acids Symp Ser 1995(33):99-102 PMID: 8643413 SCOPUS ID: 2-s2.0-0029448763 01/01/1995       6 Citations
  • Last update: 01/22/2024